TY - JOUR T1 - Hypoxic microenvironment induced spatial transcriptome changes in pancreatic cancer JF - Cancer Biology and Medicine JO - Cancer Biol Med SP - 616 LP - 630 DO - 10.20892/j.issn.2095-3941.2021.0158 VL - 18 IS - 2 AU - Huizhi Sun AU - Danfang Zhang AU - Chongbiao Huang AU - Yuhong Guo AU - Zhao Yang AU - Nan Yao AU - Xueyi Dong AU - Runfen Cheng AU - Nan Zhao AU - Jie Meng AU - Baocun Sun AU - Jihui Hao Y1 - 2021/05/01 UR - http://www.cancerbiomed.org/content/18/2/616.abstract N2 - Objective: Hypoxia is a significant feature of solid tumors, including pancreatic ductal adenocarcinoma (PDAC). It is associated with tumor invasion, metastasis, and drug resistance. However, the spatial distribution of hypoxia-related heterogeneity in PDAC remains unclear.Methods: Spatial transcriptomics (STs), a new technique, was used to investigate the ST features of engrafted human PDAC in the ischemic hind limbs of nude mice. Transcriptomes from ST spots in the hypoxic tumor and the control were clustered using differentially-expressed genes. These data were compared to determine the spatial organization of hypoxia-induced heterogeneity in PDAC. Clinical relevance was validated using the Tumor Cancer Genome Atlas and KM-plotter databases. The CMAP website was used to identify molecules that may serve as therapeutic targets for PDAC.Results: ST showed that the tumor cell subgroups decreased to 7 subgroups in the hypoxia group, compared to 9 subgroups in the control group. Different subgroups showed positional characteristics and different gene signatures. Subgroup 6 located at the invasive front showed a higher proliferative ability under hypoxia. Subgroup 6 had active functions including cell proliferation, invasion, and response to stress. Expressions of hypoxia-related genes, LDHA, TPI1, and ENO1, induced changes. CMAP analysis indicated that ADZ-6482, a PI3K inhibitor, was targeted by the invasive subgroup in hypoxic tumors.Conclusions: This study is the first to describe hypoxic microenvironment-induced spatial transcriptome changes in PDAC, and to identify potential treatment targets for PDAC. These data will provide the basis for further investigations of the prognoses and treatments of hypoxic tumors. ER -